Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients

Cancer medicine

Volumn 3, Issue 2, 2014, Pages 406-415

  Xue, Peng ^a   Kanai, Masashi ^a   Mori, Yukiko ^a   Nishimura, Takafumi ^a   Uza, Norimitsu ^a   Kodama, Yuzo ^a   Kawaguchi, Yoshiya ^a   Takaori, Kyoichi ^a   Matsumoto, Shigemi ^a   Uemoto, Shinji ^a   Chiba, Tsutomu ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; inflammation; NLR; pancreatic cancer; prognostic factor

Indexed keywords

ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG COMBINATION; ERLOTINIB; GEMCITABINE; OTERACIL; QUINAZOLINE DERIVATIVE; S 1 (COMBINATION); TEGAFUR;

AGED; ANALOGS AND DERIVATIVES; BLOOD; CARCINOMA, PANCREATIC DUCTAL; COHORT ANALYSIS; DRUG COMBINATION; FEMALE; HUMAN; LYMPHOCYTE; MALE; NEUTROPHIL; PALLIATIVE THERAPY; PANCREATIC NEOPLASMS; PATHOLOGY; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, PANCREATIC DUCTAL; COHORT STUDIES; DEOXYCYTIDINE; DRUG COMBINATIONS; FEMALE; HUMANS; LYMPHOCYTES; MALE; NEUTROPHILS; OXONIC ACID; PALLIATIVE CARE; PANCREATIC NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; QUINAZOLINES; SURVIVAL ANALYSIS; TEGAFUR; TREATMENT OUTCOME;

EID: 84907585678     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.204     Document Type: Article

References (0)